Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshitaka Inaba

Showing results (151-160 of 156) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 156 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2026
Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603Yukihide Kanemitsu, Yasuhiro Shimizu, Junki Mizusawa, et al.
Journal of Gastroenterology|November 14, 2019
REFLECT-a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subsetTatsuya Yamashita, Masatoshi Kudo, Kenji Ikeda, et al.
BMC Cancer|March 12, 2025
Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinomaYoshihisa Kodama, Kazuomi Ueshima, Michihisa Moriguchi, et al.
Anticancer Research|November 1, 2023
Novel Ureteral Stent Catheterization Technique for Treating Hyperchloremic Metabolic Acidosis After Total Pelvic ExenterationKoji Komori, Tsutomu Tanaka, Yoshitaka Inaba, et al.
Liver Cancer|January 15, 2026
Change in Liver Function after Selective Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: JIVROSG-2001 PRESIDENT-ALBI - A Secondary Analysis of a Multicenter Randomized Controlled TrialYoshihisa Kodama, Masafumi Ikeda, Yasuaki Arai, et al.
Liver Cancer|February 12, 2024
A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L TrialMasatoshi Kudo, Kazuomi Ueshima, Issei Saeki, et al.
Pageof 16

Showing results (151-160 of 156) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2026
Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603Yukihide Kanemitsu, Yasuhiro Shimizu, Junki Mizusawa, et al.
Journal of Gastroenterology|November 14, 2019
REFLECT-a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subsetTatsuya Yamashita, Masatoshi Kudo, Kenji Ikeda, et al.
BMC Cancer|March 12, 2025
Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinomaYoshihisa Kodama, Kazuomi Ueshima, Michihisa Moriguchi, et al.
Anticancer Research|November 1, 2023
Novel Ureteral Stent Catheterization Technique for Treating Hyperchloremic Metabolic Acidosis After Total Pelvic ExenterationKoji Komori, Tsutomu Tanaka, Yoshitaka Inaba, et al.
Liver Cancer|January 15, 2026
Change in Liver Function after Selective Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: JIVROSG-2001 PRESIDENT-ALBI - A Secondary Analysis of a Multicenter Randomized Controlled TrialYoshihisa Kodama, Masafumi Ikeda, Yasuaki Arai, et al.
Liver Cancer|February 12, 2024
A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L TrialMasatoshi Kudo, Kazuomi Ueshima, Issei Saeki, et al.
Pageof 16